Tag: HRS 2023
HRS 2023: BIO-LIBRA study offers insights into device treatment of non-ischaemic...
Preliminary results from the BIO-LIBRA study, assessing the outcomes of device-treated ventricular arrhythmias or mortality in patients with non-ischaemic cardiomyopathy (NICM) being treated with...
HRS 2023: Dynamic monitoring “improves access to care for AF patients”
Findings from a new clinical trial support use of implantable cardiac monitors (ICM) as a standard of care in managing patients with complex cardiac...
HRS 2023: SOLVE-CRT results “offer new hope for patients with hard-to-treat...
Results from a pivotal clinical trial found a leadless pacemaker can deliver cardiac resynchronisation therapy (CRT) among patients who were not able to be...
HRS 2023: Weight loss prior to catheter ablation improves outcomes in...
Results from a clinical trial, presented at the 2023 Heart Rhythm Society annual meeting (May 19–21, New Orleans, USA), indicate that overweight and obese...
HRS 2023: PULSED AF study demonstrates reduction in atrial arrhythmia burden...
Medtronic has announced findings from a secondary analysis of the PULSED AF study, demonstrating positive results for the Medtronic PulseSelect pulsed field ablation (PFA)...
HRS 2023: Aveir DR leadless pacemaker meets primary endpoints in IDE...
Late-breaking results from the AVEIR dual-chamber (DR) i2i Investigational Device Exemption (IDE) study, a large-scale study to assess Abbott’s Aveir dual-chamber leadless pacemaker, have...